Innova Captab Limited has informed the Exchange about Investor Presentation
INNOVACAP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Innova Captab shared its investor presentation ahead of the Q1 FY26 earnings call held on 8th August 2025. The company reported Q1 FY26 revenue of ₹351.5 crore, up 19% YoY from ₹294.3 crore, driven by new product launches and the ramp-up of its newly commissioned Jammu plant. EBITDA grew 28% YoY to ₹56.6 crore with margin expanding to 16.1% from 15.1%. PAT rose 5% YoY to ₹31.0 crore (margin 8.8%), impacted by higher depreciation and finance costs. The CDMO segment contributed ₹249.5 crore (~71% of revenue, +8% YoY), while Branded Generics surged 59% YoY to ₹102.1 crore. The company has reorganized into two focused verticals—CDMO and Branded Generics—and highlighted its Jammu facility (commercialized Jan 2025) as a key growth driver. Full-year FY25 revenue stood at ₹1,244 crore with PAT of ₹128 crore.
Positive signals for shareholders—strong revenue and EBITDA growth with margin expansion in Q1 FY26, alongside new manufacturing capacity coming online. Investors should watch Jammu plant utilization and Branded Generics momentum, which together could drive the next leg of growth, though PAT growth was modest due to higher depreciation and finance costs from new capacity.